Progress and prospects for genetic modification of nonhuman primate models in biomedical research

ILAR Journal

Volumn 54, Issue 2, 2013, Pages 211-223

  Chan, Anthony W S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Human diseases; Nonhuman primates; Transgenesis

Indexed keywords

ANIMAL; ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; DISEASE MODEL; GENE TRANSFER; GENETIC DISORDER; GENETICS; HUMAN; HUMAN DISEASES; MACACA; NONHUMAN PRIMATES; TRANSGENIC ANIMAL; TRANSGENICS;

ANIMAL MODEL; HUMAN DISEASES; NONHUMAN PRIMATES; TRANSGENESIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC DISEASES, INBORN; HUMANS; MACACA;

EID: 84887100741     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilt035     Document Type: Article

References (224)

1. Abdel-Salam OM. 2011. Stem cell therapy for Alzheimer's disease. CNS Neurol Disord Drug Targets 10:459-485.
2. Ambros V. 2003. MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing. Cell 113:673-676.
3. Ambros V. 2008. The evolution of our thinking about microRNAs. Nat Med 14:1036-1040.
4. An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM. 2012. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11:253-263.
5. Andrich J, Saft C, Ostholt N, Muller T. 2007. Complex movement behaviour and progression of Huntington's disease. Neurosci Lett 416:272-274.
6. Bachevalier J, Machado CJ, Kazama A. 2011. Behavioral outcomes of late-onset or early-onset orbital frontal cortex (areas 11/13) lesions in rhesus monkeys. Ann N YAcad Sci 1239:71-86.
7. Bachevalier J, Malkova L, Mishkin M. 2001. Effects of selective neonatal temporal lobe lesions on socioemotional behavior in infant rhesus monkeys (Macaca mulatta). Behav Neurosci 115:545-559.
8. Bachevalier J, Nemanic S. 2008. Memory for spatial location and objectplace associations are differently processed by the hippocampal formation, parahippocampal areas TH/TF and perirhinal cortex. Hippocampus 18:64-80.
9. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC. 2012. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New Engl J Med 367:795-804.
10. Bergman M, Salman H, Beloosesky Y, Djaldetti M, Bessler H. 2002. Are peripheral blood cells from patients with Alzheimer disease more sensitive to apoptotic stimuli? Alzheimer Dis Assoc Disord 16:156-160.
11. Bertelli M, Alushi B, Veicsteinas A, Jinnah HA, Micheli V. 2009. Gene expression and mRNA editing of serotonin receptor 2C in brains of HPRT gene knock-out mice, an animal model of Lesch-Nyhan disease. J Clin Neurosci 16:1061-1063.
12. Blesa J, Pifl C, Sanchez-Gonzalez MA, Juri C, Garcia-Cabezas MA, Adanez R, Iglesias E, Collantes M, Penuelas I, Sanchez-Hernandez JJ, Rodriguez-Oroz MC, Avendano C, Hornykiewicz O, Cavada C, Obeso JA. 2012. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiol Dis 48:79-91.
13. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rucker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagege A, Desnos M, Renaud JF, Menasche P, Puceat M. 2010. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120:1125-1139.
14. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D. 2005. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102:11023-11028.
15. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. 2005. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neurosci 8:1263-1268.
16. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM. 2007. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450:497-502.
17. Carbery ID, Ji D, Harrington A, Brown V, Weinstein EJ, Liaw L, Cui X. 2010. Targeted genome modification in mice using zinc-finger nucleases. Genetics 186:451-459.
18. Carter RL, Chan AW. 2012. Pluripotent stem cells models for Huntington's disease: prospects and challenges. J Genet Genomics 39:253-259.
19. Cermak T, Doyle EL, Christian M,Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39: e82.
20. Cha JH. 2007. Transcriptional signatures in Huntington's disease. Prog Neurobiol 83:228-248.
21. Chan AW, Cheng PH, Neumann A, Yang JJ. 2010. Reprogramming Huntington monkey skin cells into pluripotent stem cells. Cell Reprogram 12:509-517.
22. Chan AW, Chong KY, Martinovich C, Simerly C, Schatten G. 2001. Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 291:309-312.
23. Chan AW, Homan EJ, Ballou LU, Burns JC, Bremel RD. 1998. Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc Natl Acad Sci U S A 95:14028-14033.
24. Chan AW, Luetjens CM, Dominko T, Ramalho-Santos J, Simerly CR, Hewitson L, Schatten G. 2000a. Foreign DNA transmission by ICSI: Injection of spermatozoa bound with exogenous DNA results in embryonic GFP expression and live rhesus monkey births. Mol Hum Reprod 6:26-33.
25. Chan AW, Luetjens CM, Dominko T, Ramalho-Santos J, Simerly CR, Hewitson L, Schatten G. 2000b. TransgenICSI reviewed: Foreign DNA transmission by intracytoplasmic sperm injection in rhesus monkey. Mol Reprod Dev 56:325-328.
26. Chan AW, Luetjens CM, Schatten GP. 2000c. Sperm-mediated gene transfer. Curr Top Dev Bio 50:89-102.
27. Chan AWS. 2004. Transgenic nonhuman primates of neurodegenerative diseases. Reprod Biol Endocrinol 2:39.
28. Chan AWS, Chong KY, Schatten G. 2002. Production of transgenic primates. In: Pinkert CA, ed. Transgenic Animal Technology, 2nd edn. San Diego: Academic Press. p 359-394.
29. Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW, Ferguson D, Tsai HC, Pomeranz L, Christoffel DJ, Nectow AR, Ekstrand M, Domingos A, Mazei-Robison MS, Mouzon E, Lobo MK, Neve RL, Friedman JM, Russo SJ, Deisseroth K, Nestler EJ, Han MH. 2013. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493:532-536.
30. Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ, Justice A, McConlogue L, Games D, Freedman SB, Morris RG. 2000. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408:975-979.
31. Cooper O, Hallett P, Isacson O. 2012. Using stem cells and iPS cells to discover new treatments for Parkinson's disease. Parkinsonism Relat Disord 18 Suppl 1: S14-16.
32. Cooper O, Hargus G, Deleidi M, Blak A, Osborn T, Marlow E, Lee K, Levy A, Perez-Torres E, Yow A, Isacson O. 2010. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol Cell Neurosci 45:258-266.
33. Courtine G, Bunge MB, Fawcett JW, Grossman RG, Kaas JH, Lemon R, Maier I, Martin J, Nudo RJ, Ramon-Cueto A, Rouiller EM, Schnell L, Wannier T, Schwab ME, Edgerton VR. 2007. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med 13:561-566.
34. Crook ZR, Housman D. 2011. Huntington's disease: Can mice lead the way to treatment? Neuron 69:423-435.
35. Dawson WW, Dawson JC, Lake KP, Gonzalez-Martinez J. 2008. Maculas, monkeys, models, AMD and aging. Vision Res 48:360-365.
36. Deisseroth K. 2012. Optogenetics and psychiatry: Applications, challenges, and opportunities. Biol Psychiatry 71:1030-1032.
37. DeLong MR, Coyle JT. 1979. Globus Pallidus lesions in the monkey produced by kainic acid: Histologic and behavioral effects. Appl Neurophysiol 42:95-97.
38. Easley CA 4th, Phillips BT, McGuire MM, Barringer JM, Valli H, Hermann BP, Simerly CR, Rajkovic A, Miki T, Orwig KE, Schatten GP. 2012. Direct differentiation of human pluripotent stem cells into haploid spermatogenic cells. Cell Rep 2:440-446.
39. Ellis BL, Hirsch ML, Porter SN, Samulski RJ, Porteus MH. 2012. Zincfinger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs. Gene Ther 20:35-42.
40. Elsea SH, Lucas RE. 2002. The mousetrap: What we can learn when the mouse model does not mimic the human disease. ILAR J 43:66-79.
41. Evans M. 1996. Embryonic stem cells: The route to experimental mammalian genetics. Int J Dev Biol Suppl 1: 55S.
42. Evans M. 2008. Embryonic stem cells: the Mouse source-Vehicle for mammalian genetics and beyond (Nobel lecture). Chembiochem 9:1690-1696.
43. Ewing-Cobbs L, Prasad MR, Swank P, Kramer L, Mendez D, Treble A, Payne C, Bachevalier J. 2012. Social communication in young children with traumatic brain injury: Relations with corpus callosum morphometry. Int J Dev Neurosci 30:247-254.
44. Fairchild PJ. 2010. The challenge of immunogenicity in the quest for induced pluripotency. Nat Rev Immunol 10:868-875.
45. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas CF 3rd. 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9:805-807.
46. Gallo P, Cupic D, Bracco F, Krzalic L, Tavolato B, Battistin L. 1989. Experimental allergic encephalomyelitis in the monkey: Humoral immunity and blood-brain barrier function. Ital J Neurol Sci 10:561-565.
47. Geevasinga N, Richards FH, Jones KJ, Ryan MM. 2006. Juvenile Huntington disease. J Paediatr Child Health 42:552-554.
48. Gerits A, Farivar R, Rosen BR, Wald LL, Boyden ES, Vanduffel W. 2012. Optogenetically induced behavioral and functional network changes in primates. Curr Biol 22:1722-1726.
49. Gilley J, Adalbert R, Coleman MP. 2011. Modelling early responses to neurodegenerative mutations in mice. Biochem Soc Trans 39:933-938.
50. Glogowski S, Ward KW, Lawrence MS, Goody RJ, Proksch JW. 2012. The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies. J Ocul Pharmacol Ther 28:290-298.
51. Golding MC, Long CR, Carmell MA, Hannon GJ, Westhusin ME. 2006. Suppression of prion protein in livestock by RNA interference. Proc Natl Acad Sci U S A 103:5285-5290.
52. Grossniklaus HE, Kang SJ, Berglin L. 2010. Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29:500-519.
53. HD iPSC Consortium. 2012. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11:264-278.
54. Huntington Study Group. 1996. Unified Huntington's Disease Rating Scale: Reliability and consistency. Mov Disord 11:136-142.
55. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
56. Han X, Qian X, Bernstein JG, Zhou HH, Franzesi GT, Stern P, Bronson RT, Graybiel AM, Desimone R, Boyden ES. 2009. Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron 62:191-198.
57. Hauschild-Quintern J, Petersen B, Queisser AL, Lucas-Hahn A, Schwinzer R, Niemann H. 2013. Gender non-specific efficacy of ZFN mediated gene targeting in pigs. Transgenic Res 22:1-3.
58. Hauschild J, Petersen B, Santiago Y, Queisser AL, Carnwath JW, Lucas-Hahn A, Zhang L, Meng X, Gregory PD, Schwinzer R, Cost GJ, Niemann H. 2011. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A 108:12013-12017.
59. Hermann BP, Sukhwani M, Winkler F, Pascarella JN, Peters KA, Sheng Y, Valli H, Rodriguez M, Ezzelarab M, Dargo G, Peterson K, Masterson K, Ramsey C, Ward T, Lienesch M, Volk A, Cooper DK, Thomson AW, Kiss JE, Penedo MC, Schatten GP, Mitalipov S, Orwig KE. 2012. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell 11:715-726.
60. Hewitson L, Simerly CR, Schatten G. 2002. Fate of sperm components during assisted reproduction: Implications for infertility. Hum Fertil (Camb) 5:110-116.
61. Hitz C, Steuber-Buchberger P, Delic S,WurstW, Kuhn R. 2009. Generation of shRNA transgenic mice. Methods Mol Biol 530:101-129.
62. Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, Snowden J, Thompson J, Esmonde T, Gentry R, Moore JW, Bodner T. 2003. Profile of cognitive progression in early Huntington's disease. Neurology 61:1702-1706.
63. Hobbs NZ, Barnes J, Frost C, Henley SM, Wild EJ, Macdonald K, Barker RA, Scahill RI, Fox NC, Tabrizi SJ. 2010a. Onset and progression of pathologic atrophy in Huntington disease: A longitudinal MR imaging study. AJNR Am J Neuroradiol 31:1036-1041.
64. Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ. 2010b. The progression of regional atrophy in premanifest and early Huntington's disease: A longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry 81:756-763.
65. Hogan B. 1994. Manipulating the Mouse Embryo: A Laboratory Manual, 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press.
66. Hogstedt S, Lindberg BS, Regardh CG, Mostrom U, Rane A. 1990. The rhesus monkey as a model for studies of pregnancy induced changes in metoprolol metabolism. Pharmacol Toxicol 66:32-36.
67. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
68. Hwang DY, Kim DS, Kim DW. 2010. Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: Current state and problems. J Cell Biochem 109:292-301.
69. Hyun I, Hochedlinger K, Jaenisch R, Yamanaka S. 2007. New advances in iPS cell research do not obviate the need for human embryonic stem cells. Cell Stem Cell 1:367-368.
70. Jarvis P, Srivastav S, Vogelwedde E, Stewart J, Mitchard T, Weinbauer GF. 2010. The cynomolgus monkey as a model for developmental toxicity studies: Variability of pregnancy losses, statistical power estimates, and group size considerations. Birth Defects Res B Dev Reprod Toxicol 89:175-187.
71. Jinnah HA, Gage FH, Friedmann T. 1990. Animal models of Lesch-Nyhan syndrome. Brain Res Bull 25:467-475.
72. Joyner AL, Skarnes WC, Rossant J. 1989. Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells. Nature 338:153-156.
73. Kadereit S, Trounson A. 2011. In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages. Semin Immunopathol 33:551-562.
74. Kanazawa I, Kimura M, Murata M, Tanaka Y, Cho F. 1990. Choreic movements in the macaque monkey induced by kainic acid lesions of the striatum combined with L-dopa. Pharmacological, biochemical and physiological studies on neural mechanisms. Brain 113 (Pt 2):509-535.
75. Kang SJ, Grossniklaus HE. 2011. Rabbit model of retinoblastoma. J Biomed Biotechnol 2011: 394730.
76. Kao LM, Bush K, Barnewall R, Estep J, Thalacker FW, Olson PH, Drusano GL, Minton N, Chien S, Hemeryck A, Kelley MF. 2006. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model. Antimicrob Agents Chemother 50:3535-3542.
77. Kim K, Doi A,Wen B, Ng K, Zhao R, Cahan P, Kim J, AryeeMJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ. 2010. Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290.
78. King FG, Dedrick RL. 1979. Pharmacokinetic model for 2-amino-1,3,4-thiadiazole in mouse, dog, and monkey. Cancer Treat Rep 63:1939-1947.
79. Klempir J, Klempirova O, Spackova N, Zidovska J, Roth J. 2006. Unified Huntington's disease rating scale: Clinical practice and a critical approach. Funct Neurol 21:217-221.
80. Kobayashi M, Horiuchi H, Fujita K, Takuhara Y, Suzuki S. 2012. Characterization of grape C-repeat-binding factor 2 and B-box-type zinc finger protein in transgenic Arabidopsis plants under stress conditions. Mol Biol Rep 39:7933-7939.
81. Koller BH, Smithies O. 1989. Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci U S A 86:8932-8935.
82. Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S, Roitberg BZ, Emborg M, Hantraye P, Deglon N, Aebischer P. 1999. Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160:1-16.
83. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, BrownWD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
84. Kravitz AV, Freeze BS, Parker PR, Kay K, Thwin MT, Deisseroth K, Kreitzer AC. 2010. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466:622-626.
85. Kundu MC, May MC, Chosich J, Bradford AP, Lasley B, Gee N, Santoro N, Appt SE, Polotsky AJ. 2013. Assessment of luteal function in the vervet monkey as a means to develop a model for obesity-related reproductive phenotype. Syst Biol Reprod Med. Epub Date 2013/01/03.
86. Lavitrano M, Camaioni A, Fazio VM, Dolci S, Farace MG, Spadafora C. 1989. Sperm cells as vectors for introducing foreign DNA into eggs: Genetic transformation of mice. Cell 57:717-723.
87. Lavitrano M, Busnelli M, Cerrito MG, Giovannoni R, Manzini, Vargiolu A. 2006. Sperm-mediated gene transfer. Reprod Fertil Develop.18:19-23.
88. Lavitrano M, Giovannoni R, Cerrito MG. 2013. Methods for spermmediated gene transfer. Methods Mol Biol 927:519-529.
89. Lee EW, Garner CD, Terzo TS. 1994. Animal model for the study of methanol toxicity: Comparison of folate-reduced rat responses with published monkey data. J Toxicol Environ Health 41:71-82.
90. Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison P, Nance M, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa E, Ayuso C, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali M, Jones R, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente D, Harrison MB, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, Landwehrmeyer GB, Myers RH, Macdonald ME, Gusella JF. 2012. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78:690-695.
91. Lemon RN, Kirkwood PA, Maier MA, Nakajima K, Nathan P. 2004. Direct and indirect pathways for corticospinal control of upper limb motoneurons in the primate. Prog Brain Res 143:263-279.
92. Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ. 2001. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet 10:137-144.
93. Liu A, Xie S, Sun H, Gonzalez FJ,Wei X, Dai R. 2009. Myotoxicity of gemfibrozil in cynomolgus monkey model and its relationship to pharmacokinetic properties. Toxicol Appl Pharmacol 235:287-295.
94. Liu J, Li C, Yu Z, Huang P,Wu H,Wei C, Zhu N, Shen Y, Chen Y, Zhang B, Deng WM, Jiao R. 2012. Efficient and specific modifications of the drosophila genome by means of an easy TALEN strategy. J Genet Genomics 39:209-215.
95. Livesey FJ. 2012. Stem cell models of Alzheimer's disease and related neurological disorders. Alzheimers Res Ther 4:44.
96. Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, Kim KA, Ando D, Urnov FD, Galli C, Gregory PD, Holmes MC, Naldini L. 2007. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25:1298-1306.
97. Lunn JS, Sakowski SA, Federici T, Glass JD, Boulis NM, Feldman EL. 2011. Stem cell technology for the study and treatment of motor neuron diseases. Regen Med 6:201-213.
98. Lutz RJ, Dedrick RL, Tuey D, Sipes IG, Anderson MW, Matthews HB. 1984. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model. Drug Metab Dispo 12:527-535.
99. Mahfouz MM, Li L, Shamimuzzaman M, Wibowo A, Fang X, Zhu JK. 2011. De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates doublestrand breaks. Proc Natl Acad Sci U S A 108:2623-2628.
100. Marchetto MC, Brennand KJ, Boyer LF, Gage FH. 2011. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Hum Mol Genet 20:R109-115.
101. Marsh JL, Pallos J, Thompson LM. 2003. Fly models of Huntington's disease. Hum Mol Genet 12 Spec No 2:R187-193.
102. Maury Y, Gauthier M, Peschanski M, Martinat C. 2012. Human pluripotent stem cells for disease modelling and drug screening. Bioessays 34:61-71.
103. Meissner A, Jaenisch. 2006. Mammalian nuclear transfer. Dev Dyn 235:2460-2469.
104. Melo EO, Canavessi AM, Franco MM, Rumpf R. 2007. Animal transgenesis: State of the art and applications. J Appl Genet 48:47-61.
105. Mitalipov SM, Wolf DP. 2006. Nuclear transfer in nonhuman primates. Methods Mol Biol 348:151-168.
106. Mittoux V, Joseph JM, Conde F, Palfi S, Dautry C, Poyot T, Bloch J, Deglon N, Ouary S, Nimchinsky EA, Brouillet E, Hof PR, Peschanski M, Aebischer P, Hantraye P. 2000. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Hum Gene Ther 11:1177-1187.
107. Morocz M, Kalman J, Juhasz A, Sinko I, McGlynn AP, Downes CS, Janka Z, Rasko I. 2002. Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease. Neurobiol Aging 23:47-53.
108. Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, Oliver A, Quaid K, Ringman JM, Rossor MN, Salloway S, Schofield PR, Selsor NJ, Sperling RA, Weiner MW, Xiong C, Moulder KL, Buckles VD. 2012. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) 2:975-984.
109. Naldini L. 1998. Lentiviruses as gene transfer agents for delivery to nondividing cells. Curr Opin Biotechnol 9:457-463.
110. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93:11382-11388.
111. Nichols J, Evans EP, Smith AG.1990. Establishment of germ-linecompetent embryonic stem (ES) cells using differentiation inhibiting activity. Development 110:1341-1348.
112. Niemann H, KuesWA. 2003. Application of transgenesis in livestock for agriculture and biomedicine. Anim Reprod Sci 79:291-317.
113. Niu Y, Yu Y, Bernat A, Yang S, He X, Guo X, Chen D, Chen Y, Ji S, SiW, Lv Y, Tan T, Wei Q, Wang H, Shi L, Guan J, Zhu X, Afanassieff M, Savatier P, Zhang K, Zhou Q, Ji W. 2010. Transgenic rhesus monkeys produced by gene transfer into early-cleavage-stage embryos using a simian immunodeficiency virus-based vector. Proc Natl Acad Sci U S A 107:17663-17667.
114. O'Sullivan A, He X, McNiven EM, Hinde K, Haggarty NW, Lonnerdal B, Slupsky CM. 2012. Metabolomic phenotyping validates the infant rhesus monkey as a model of human infant metabolism. J Pediatr Gastroenterol Nutr Epub Date 2012/12/04.
115. Obaldia N 3rd, Otero W, Marin C, Aparicio J, Cisneros G. 2011. Long-term effect of a simple nest-box on the reproductive efficiency and other life traits of an Aotus lemurinus lemurinus monkey colony: An animal model for malaria research. J Med Primatol 40:383-391.
116. Okano H, Hikishima K, Iriki A, Sasaki E. 2012. The common marmoset as a novel animal model system for biomedical and neuroscience research applications. Semin Fetal Neonatal Med 17:336-340.
117. Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, Conde F, Li XJ, Aebischer P, Hantraye P, Deglon N. 2007. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol Ther 15:1444-1451.
118. Pandya S, Klimatcheva E, Planelles V. 2001. Lentivirus and foamy virus vectors: Novel gene therapy tools. Expert Opin Biol Ther 1:17-40.
119. Passananti C, Corbi N, Onori A, Di Certo MG, Mattei E. 2010. Transgenic mice expressing an artificial zinc finger regulator targeting an endogenous gene. Methods Mol Biol 649:183-206.
120. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M. 2008. Detection of Huntington's disease decades before diagnosis: The Predict-HD study. J Neurol Neurosurg Psychiatry 79:874-880.
121. Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC. 2006. Brain structure in preclinical Huntington's disease. Biol Psychiatry 59:57-63.
122. Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M. 2010. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201-207.
123. Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J. 2010. Cognitive and functional decline in Huntington's disease: Dementia criteria revisited. Mov Disord 25:1163-1169.
124. Perrier A, Peschanski M. 2012. How can human pluripotent stem cells help decipher and cure Huntington's disease? Cell Stem Cell 11:153-161.
125. Perry AC, Wakayama T, Kishikawa H, Kasai T, Okabe M, Toyoda Y, Yanagimachi R. 1999. Mammalian transgenesis by intracytoplasmic sperm injection. Science 284:1180-1183.
126. Pfeifer A. 2004. Lentiviral transgenesis. Transgenic Res 13:513-522.
127. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
128. Putkhao K, Kocerha J, Cho IK, Yang J, Parnpai R, Chan AW. 2013. Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease. Stem Cells Dev Epub Date 2012/ 11/30.
129. Rahman SH, Bobis-Wozowicz S, Chatterjee D, Gellhaus K, Pars K, Heilbronn R, Jacobs R, Cathomen T. 2013. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum Gene Ther 24:67-77.
130. Rasmussen A, Macias R, Yescas P, Ochoa A, Davila G, Alonso E. 2000. Huntington disease in children: Genotype-phenotype correlation. Neuropediatrics 31:190-194.
131. Raymond CS, Zhu L, Vogt TF, Shin MK. 2010. In vivo analysis of gene knockdown in tetracycline-inducible shRNA mice. Methods Enzymol 477:415-427.
132. Ribai P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dode C, Brice A, Durr A. 2007. Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients. Arch Neurol 64:813-819.
133. Rice J. 2012. Animal models: Not close enough. Nature 484:S9-S9.
134. Rideout WM 3rd, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109: 17-27.
135. Roos RA. 2010. Huntington's disease: A clinical review. Orphanet J Rare Dis 5:40.
136. Ross CA, Shoulson I. 2009. Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics. Parkinsonism Relat Disord 15 Suppl 3: S135-138.
137. Rubinsztein DC. 2002. Lessons from animal models of Huntington's disease. Trends Genet 18:202-209.
138. Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, Regulier E, Delorenzi M, Tabrizi SJ, Luthi-Carter R. 2007. Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci U S A 104:14424-14429.
139. Ruocco HH, Lopes-Cendes I, Laurito TL, Li LM, Cendes F. 2006. Clinical presentation of juvenile Huntington disease. Arq Neuropsiquiatr 64:5-9.
140. Saha K, Jaenisch R. 2009. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5:584-595.
141. Sanchez-Danes A, Richaud-Patin Y, Carballo-Carbajal I, Jimenez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, Canals JM, Memo M, Alberch J, Lopez-Barneo J, Vila M, Cuervo AM, Tolosa E, Consiglio A, Raya A. 2012. Disease-specific phenotypes in dopamine neurons from human iPSbased models of genetic and sporadic Parkinson's disease. EMBOMol Med 4:380-395.
142. Sasaki E, Suemizu H, Shimada A, Hanazawa K, Oiwa R, Kamioka M, Tomioka I, Sotomaru Y, Hirakawa R, Eto T, Shiozawa S, Maeda T, Ito M, Ito R, Kito C, Yagihashi C, Kawai K, Miyoshi H, Tanioka Y, Tamaoki N, Habu S, Okano H, Nomura T. 2009. Generation of transgenic non-human primates with germline transmission. Nature 459:523-527.
143. Schnieke AE, Kind AJ, Ritchie WA, Mycock K, Scott AR, Ritchie M, Wilmut I, Colman A, Campbell KH. 1997. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278:2130-2133.
144. Seibler J, Kleinridders A, Kuter-Luks B, Niehaves S, Bruning JC, Schwenk F. 2007. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res 35: e54.
145. Seibler J, Kuter-Luks B, Kern H, Streu S, Plum L, Mauer J, Kuhn R, Bruning JC, Schwenk F. 2005. Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 33: e67.
146. Shimazu H, Maier MA, Cerri G, Kirkwood PA, Lemon RN. 2004. Macaque ventral premotor cortex exerts powerful facilitation of motor cortex outputs to upper limb motoneurons. J Neurosci 24:1200-1211.
147. Simerly C, Dominko T, Navara C, Payne C, Capuano S, Gosman G, Chong KY, Takahashi D, Chace C, Compton D, Hewitson L, Schatten G. 2003. Molecular correlates of primate nuclear transfer failures. Science 300:297.
148. Simerly CR, Navara CS. 2003. Nuclear transfer in the rhesus monkey: Opportunities and challenges. Cloning Stem Cells 5:319-331.
149. Smith K, Dillingham L, Giddens WE Jr. 1978. Metabolic bone disease resembling osteosarcoma in a wooly monkey (Lagothrix lagotricha). Lab Anim Sci 28:451-456.
150. Solomon AC, Stout JC, Weaver M, Queller S, Tomusk A, Whitlock KB, Hui SL, Marshall J, Jackson JG, Siemers ER, Beristain X, Wojcieszek J, Foroud T. 2008. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord 23:1830-1836.
151. Sommer JR, Jackson LR, Simpson SG, Collins EB, Piedrahita JA, Petters RM. 2012. Transgenic Stra8-EYFP pigs: A model for developing male germ cell technologies. Transgenic Res 21:383-392.
152. Sritharan A, Egan GF, Johnston L, Horne M, Bradshaw JL, Bohanna I, Asadi H, Cunnington R, Churchyard AJ, Chua P, Farrow M, Georgiou-Karistianis N. 2010. A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry 81:257-262.
153. Stieger K, Lheriteau E, Moullier P, Rolling F. 2009. AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J 50:206-224.
154. Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH. 2011. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25:1-14.
155. Strange TL, Petolino JF. 2012. Targeting DNA to a previously integrated transgenic locus using zinc finger nucleases. Methods Mol Biol 847:391-397.
156. Suarez-Alvarez B, Rodriguez RM, Calvanese V, Blanco-Gelaz MA, Suhr ST, Ortega F, Otero J, Cibelli JB, Moore H, Fraga MF, Lopez-Larrea C. 2010. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One 5:e10192.
157. Sun Q, Dong J, Yang W, Jin Y, Yang M, Wang Y, Wang PL, Hu Y, Tsien JZ. 2008. Efficient reproduction of cynomolgus monkey using pronuclear embryo transfer technique. Proc Natl Acad Sci U S A 105:12956-12960.
158. Sung YH, Baek IJ, Kim DH, Jeon J, Lee J, Lee K, Jeong D, Kim JS, Lee HW. 2013. Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol 31:23-24.
159. Sung YH, Baek IJ, Seong JK, Kim JS, Lee HW. 2012. Mouse genetics: Catalogue and scissors. BMB Rep 45:686-692.
160. Tabchy A, Housman D. 2006. Huntington's disease: A transcriptional report card from the peripheral blood: Can it measure disease progression in Huntington's disease? Eur J Hum Genet 14:649-650.
161. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC. 2009. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol 8:791-801.
162. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR. 2012. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol 11:42-53.
163. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC. 2011. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurol 10:31-42.
164. Tachibana M, Sparman M, Ramsey C, Ma H, Lee HS, Penedo MC, Mitalipov S. 2012. Generation of chimeric rhesus monkeys. Cell 148:285-295.
165. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
166. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
167. Tessanne K, Golding MC, Long CR, Peoples MD, Hannon G, Westhusin ME. 2012. Production of transgenic calves expressing an shRNA targeting myostatin. Mol Reprod Dev 79:176-185.
168. Thomas J, Carver M, Haisch C, Thomas F,Welch J, Carchman R. 1982. Differential effects of intravenous anaesthetic agents on cell-mediated immunity in the Rhesus monkey. Clin Exp Immunol 47:457-466.
169. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
170. Thomson JA, Marshall VS. 1998. Primate embryonic stem cells. Curr Top Dev Biol 38:133-165.
171. Tiscornia G, Vivas EL, Izpisua Belmonte JC. 2011. Diseases in a dish: Modeling human genetic disorders using induced pluripotent cells. Nat Med 17:1570-1576.
172. Tsunematsu T, Kilduff TS, Boyden ES, Takahashi S, Tominaga M, Yamanaka A. 2011. Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 31:10529-10539.
173. Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, Yao J, Redenti S, Daley GQ, Young MJ. 2011. Transplantation of adult mouse iPS cellderived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One 6: e18992.
174. Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, Kim SY, Adhikari A, Thompson KR, Andalman AS, Gunaydin LA, Witten IB, Deisseroth K. 2013. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493:537-541.
175. Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM. 2000. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 86:737-744.
176. Vaccarino AL, Anderson K, Borowsky B, Duff K, Giuliano J, Guttman M, Ho AK, Orth M, Paulsen JS, Sills T, van Kammen DP, Evans KR. 2011. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in Huntington disease gene expansion carriers. Mov Disord 26:877-884.
177. Vaitukaitis JL. 1998. Animal models of human disease for the 21st century. Lab Anim Sci 48:562-564.
178. Van Pham P, Vu NB, Duong TT, Nguyen TT, Truong NH, Phan NL, Vuong TG, Pham VQ, Nguyen HM, Nguyen KT, Nguyen NT, Nguyen KG, Khat LT, Van Le D, Truong KD, Phan NK. 2012. Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment. Onco Targets Ther 5:77-84.
179. Vandenberghe W, Demaerel P, Dom R, Maes F. 2009. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 256:109-114.
180. Vezoli J, Fifel K, Leviel V, Dehay C, Kennedy H, Cooper HM, Gronfier C, Procyk E. 2011. Early presymptomatic and long-term changes of rest activity cycles and cognitive behavior in a MPTP-monkey model of Parkinson's disease. PLoS One 6: e23952.
181. von Horsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira- Saecker AM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O. 2003. Transgenic rat model of Huntington's disease. Hum Mol Genet 12:617-624.
182. Wakayama T. 2007. Production of cloned mice and ES cells from adult somatic cells by nuclear transfer: how to improve cloning efficiency? J Reprod Dev. 53:13-26.
183. Wakayama T, Yanagimachi R. 2001. Mouse cloning with nucleus donor cells of different age and type. Mol Reprod Dev 58:376-383.
184. Walker FO. 2007. Huntington's disease. Lancet 369:218-228.
185. Weaver KE, Richards TL, Liang O, LaurinoMY, Samii A, Aylward EH. 2009. Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 216:525-529.
186. Whyte JJ, Prather RS. 2012. Cell Biology Symposium: Zinc finger nucleases to create custom-designed modifications in the swine (Sus scrofa) genome. J Anim Sci 90:1111-1117.
187. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385:810-813.
188. Wolf DP. 2009. Artificial insemination and the assisted reproductive technologies in non-human primates. Theriogenology 71:123-129.
189. Woodman B, Butler R, Landles C, Lupton MK, Tse J, Hockly E, Moffitt H, Sathasivam K, Bates GP. 2007. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72:83-97.
190. Xia XG, Zhou H, Samper E, Melov S, Xu Z. 2006. Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2: e10.
191. Yang SH, Chan AW. 2011. Transgenic animal models of Huntington's disease. Curr Top Behav Neurosci 7:61-85.
192. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW. 2008a. Towards a transgenic model of Huntington's disease in a non-human primate. Nature 453:921-924.
193. Yang SH, Cheng PH, Sullivan RT, Thomas JW, Chan AW. 2008b. Lentiviral integration preferences in transgenic mice. Genesis 46:711-718.
194. Yang X, Smith SL, Tian XC, Lewin HA, Renard JP,Wakayama T. 2007. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet 39:295-302.
195. Young JE, Goldstein LS. 2012. Alzheimer's disease in a dish: Promises and challenges of human stem cell models. Hum Mol Genet 21:R82-89.
196. Zeiss CJ. 2010. Animals as models of age-related macular degeneration: An imperfect measure of the truth. Vet Pathol 47:396-413.
197. Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R. 1989. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342:435-438.
198. Zimmer A, Gruss P. 1989. Production of chimaeric mice containing embryonic stem (ES) cells carrying a homoeobox Hox 1.1 allele mutated by homologous recombination. Nature 338:150-153.
199. Zschemisch NH, Glage S, Wedekind D, Weinstein EJ, Cui X, Dorsch M, Hedrich HJ. 2012. Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol 13: 60.
200. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
201. Woodman B, Butler R, Landles C, Lupton MK, Tse J, Hockly E, Moffitt H, Sathasivam K, Bates GP. 2007. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72:83-97
202. Xia XG, Zhou H, Samper E, Melov S, Xu Z. 2006. Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2: e10.
203. Yang SH, Chan AW. 2011. Transgenic animal models of Huntington's disease. Curr Top Behav Neurosci 7:61-85.
204. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW. 2008a. Towards a transgenic model of Huntington's disease in a non-human primate. Nature 453:921-924.
205. Yang SH, Cheng PH, Sullivan RT, Thomas JW, Chan AW. 2008b. Lentiviral integration preferences in transgenic mice. Genesis 46:711-718.
206. Yang X, Smith SL, Tian XC, Lewin HA, Renard JP,Wakayama T. 2007. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet 39:295-302.
207. Young JE, Goldstein LS. 2012. Alzheimer's disease in a dish: Promises and challenges of human stem cell models. Hum Mol Genet 21:R82-89.
208. Zeiss CJ. 2010. Animals as models of age-related macular degeneration: An imperfect measure of the truth. Vet Pathol 47:396-413.
209. Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R. 1989. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342:435-438.
210. Zimmer A, Gruss P. 1989. Production of chimaeric mice containing embryonic stem (ES) cells carrying a homoeobox Hox 1.1 allele mutated by homologous recombination. Nature 338:150-153.
211. Zschemisch NH, Glage S, Wedekind D, Weinstein EJ, Cui X, Dorsch M, Hedrich HJ. 2012. Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol 13: 60.
212. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.
213. Woodman B, Butler R, Landles C, Lupton MK, Tse J, Hockly E, Moffitt H, Sathasivam K, Bates GP. 2007. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72:83-97.
214. Xia XG, Zhou H, Samper E, Melov S, Xu Z. 2006. Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2: e10.
215. Yang SH, Chan AW. 2011. Transgenic animal models of Huntington's disease. Curr Top Behav Neurosci 7:61-85.
216. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW. 2008a. Towards a transgenic model of Huntington's disease in a non-human primate. Nature 453:921-924.
217. Yang SH, Cheng PH, Sullivan RT, Thomas JW, Chan AW. 2008b. Lentiviral integration preferences in transgenic mice. Genesis 46:711-718.
218. Yang X, Smith SL, Tian XC, Lewin HA, Renard JP,Wakayama T. 2007. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet 39:295-302.
219. Young JE, Goldstein LS. 2012. Alzheimer's disease in a dish: Promises and challenges of human stem cell models. Hum Mol Genet 21:R82-89.
220. Zeiss CJ. 2010. Animals as models of age-related macular degeneration: An imperfect measure of the truth. Vet Pathol 47:396-413.
221. Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R. 1989. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342:435-438.
222. Zimmer A, Gruss P. 1989. Production of chimaeric mice containing embryonic stem (ES) cells carrying a homoeobox Hox 1.1 allele mutated by homologous recombination. Nature 338:150-153.
223. Zschemisch NH, Glage S, Wedekind D, Weinstein EJ, Cui X, Dorsch M, Hedrich HJ. 2012. Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol 13: 60.
224. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873-9880.